Caption Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,400
Closed -$2.37M 1774
2026
Q1
$1.87M Buy
6,400
+4,250
+198% +$1.4M 0.01% 839
2025
Q4
$754K Sell
2,150
-1,000
-32% -$338K 0.01% 1150
2025
Q3
$1.02M Buy
+3,150
New +$980K 0.01% 1100
2025
Q1
Sell
-7,065
Closed -$2.61M 1657
2024
Q4
$2.61M Buy
+7,065
New +$2.96M 0.02% 607
2024
Q3
Sell
-300
Closed -$163K 1371
2024
Q2
$163K Buy
+300
New +$159K ﹤0.01% 981
2020
Q3
Sell
-19,000
Closed -$5M 1086
2020
Q2
$5M Buy
+19,000
New +$5.07M 0.17% 164

Other funds holding ELV

Caption Management's ELV Position: Q2 2026 in Review

Caption Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 6,400 shares — an estimated $2.37M sold.

Caption Management first reported a position in ELV in Q2 2020 and held it in 6 quarters. The position peaked at $5M in Q2 2020. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Caption Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 6,400 Elevance Health shares in Q2 2026, an estimated $2.37M.
  • Caption Management first reported a position in Elevance Health in Q2 2020 and held it in 6 quarters.
  • Caption Management's Elevance Health position peaked at $5M in Q2 2020.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.